These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. Klunker S; Chong MM; Mantel PY; Palomares O; Bassin C; Ziegler M; Rückert B; Meiler F; Akdis M; Littman DR; Akdis CA J Exp Med; 2009 Nov; 206(12):2701-15. PubMed ID: 19917773 [TBL] [Abstract][Full Text] [Related]
68. Critical co-stimulatory pathways in the stability of Foxp3+ Treg cell homeostasis in Type I diabetes. Kornete M; Piccirillo CA Autoimmun Rev; 2011 Dec; 11(2):104-11. PubMed ID: 21875694 [TBL] [Abstract][Full Text] [Related]
69. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Luo CT; Liao W; Dadi S; Toure A; Li MO Nature; 2016 Jan; 529(7587):532-6. PubMed ID: 26789248 [TBL] [Abstract][Full Text] [Related]
70. The regulation of FoxP3-expressing regulatory T cells. Haque R; Lei F; Xiong X; Song J Endocr Metab Immune Disord Drug Targets; 2011 Dec; 11(4):334-46. PubMed ID: 21696363 [TBL] [Abstract][Full Text] [Related]
71. Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy. Verhagen J; Wegner A; Wraith DC Immunology; 2015 Jun; 145(2):171-81. PubMed ID: 25716063 [TBL] [Abstract][Full Text] [Related]
72. Stabilizing human regulatory T cells for tolerance inducing immunotherapy. He X; Koenen HJ; Slaats JH; Joosten I Immunotherapy; 2017 Aug; 9(9):735-751. PubMed ID: 28771099 [TBL] [Abstract][Full Text] [Related]
73. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells. Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433 [TBL] [Abstract][Full Text] [Related]
74. Antigen-induced regulatory T cells in autoimmunity. von Herrath MG; Harrison LC Nat Rev Immunol; 2003 Mar; 3(3):223-32. PubMed ID: 12658270 [TBL] [Abstract][Full Text] [Related]
75. Extrathymic generation of regulatory T cells--chances and challenges for prevention of autoimmune disease. Daniel C; von Boehmer H Adv Immunol; 2011; 112():177-213. PubMed ID: 22118409 [TBL] [Abstract][Full Text] [Related]
76. mTOR signaling, Tregs and immune modulation. Chapman NM; Chi H Immunotherapy; 2014; 6(12):1295-311. PubMed ID: 25524385 [TBL] [Abstract][Full Text] [Related]
77. Exploring the controversial role of PI3K signalling in CD4 Poli A; Fiume R; Mongiorgi S; Zaurito A; Sheth B; Vidalle MC; Hamid SA; Kimber S; Campagnoli F; Ratti S; Rusciano I; Faenza I; Manzoli L; Divecha N Adv Biol Regul; 2020 May; 76():100722. PubMed ID: 32362560 [TBL] [Abstract][Full Text] [Related]
78. The role of natural regulatory T cells in infection. Sanchez AM; Yang Y Immunol Res; 2011 Apr; 49(1-3):124-34. PubMed ID: 21116872 [TBL] [Abstract][Full Text] [Related]
79. Regulatory T Cells and Human Disease. Sakaguchi S; Mikami N; Wing JB; Tanaka A; Ichiyama K; Ohkura N Annu Rev Immunol; 2020 Apr; 38():541-566. PubMed ID: 32017635 [TBL] [Abstract][Full Text] [Related]
80. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis. Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]